Women's healthcare vendor Hologic plans to debut a new breast biopsy device as well as a computer-aided detection (CAD) unit at the upcoming National Consortium of Breast Centers (NCBC) annual meeting in Las Vegas.
On the heels of the U.S. Food and Drug Administration's (FDA) clearance of the company's Selenia Dimensions 3D digital breast tomosynthesis system, Hologic plans to highlight two new products designed for the system: Affirm upright breast biopsy guidance and ImageChecker 3D Calc CAD.
Affirm is cleared for sale in the U.S., but ImageChecker 3D Calc is a work-in-progress and is not yet available for sale, according to Hologic.
